The Diagnostic Assessment of Canine Lymphoma

Implications for Treatment

Dorothee Bienzle, William Vernau

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Lymphoma in dogs is a heterogeneous cancer with highly variable prognosis. Many types of canine lymphoma have similar counterparts in the World Health Organization classification of human lymphoid tumors. The most common variant of canine lymphoma is diffuse large B-cell lymphoma, which, if treated with multiagent chemotherapy, has a survival time of approximately 12 months. T-cell lymphomas are more heterogeneous and high- and low-grade variants are common, which necessitates classification beyond B- versus T-cell lineage.

Original languageEnglish (US)
Pages (from-to)21-39
Number of pages19
JournalClinics in Laboratory Medicine
Volume31
Issue number1
DOIs
StatePublished - Mar 2011

Fingerprint

T-cells
Canidae
Lymphoma
Chemotherapy
Lymphoma, Large B-Cell, Diffuse
T-Cell Lymphoma
B-Cell Lymphoma
Cell Lineage
Tumors
Neoplasms
Cells
Health
Dogs
T-Lymphocytes
Drug Therapy
Survival
Therapeutics

Keywords

  • Clonal antigen receptor polymerase chain reaction
  • Flow cytometry
  • Immunohistochemistry
  • Lymphosarcoma
  • Veterinary
  • WHO classification

ASJC Scopus subject areas

  • Biochemistry, medical
  • Clinical Biochemistry

Cite this

The Diagnostic Assessment of Canine Lymphoma : Implications for Treatment. / Bienzle, Dorothee; Vernau, William.

In: Clinics in Laboratory Medicine, Vol. 31, No. 1, 03.2011, p. 21-39.

Research output: Contribution to journalArticle

@article{02ed669f1b9a42e1b734d71dd7a38fe1,
title = "The Diagnostic Assessment of Canine Lymphoma: Implications for Treatment",
abstract = "Lymphoma in dogs is a heterogeneous cancer with highly variable prognosis. Many types of canine lymphoma have similar counterparts in the World Health Organization classification of human lymphoid tumors. The most common variant of canine lymphoma is diffuse large B-cell lymphoma, which, if treated with multiagent chemotherapy, has a survival time of approximately 12 months. T-cell lymphomas are more heterogeneous and high- and low-grade variants are common, which necessitates classification beyond B- versus T-cell lineage.",
keywords = "Clonal antigen receptor polymerase chain reaction, Flow cytometry, Immunohistochemistry, Lymphosarcoma, Veterinary, WHO classification",
author = "Dorothee Bienzle and William Vernau",
year = "2011",
month = "3",
doi = "10.1016/j.cll.2010.10.001",
language = "English (US)",
volume = "31",
pages = "21--39",
journal = "Clinics in Laboratory Medicine",
issn = "0272-2712",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - The Diagnostic Assessment of Canine Lymphoma

T2 - Implications for Treatment

AU - Bienzle, Dorothee

AU - Vernau, William

PY - 2011/3

Y1 - 2011/3

N2 - Lymphoma in dogs is a heterogeneous cancer with highly variable prognosis. Many types of canine lymphoma have similar counterparts in the World Health Organization classification of human lymphoid tumors. The most common variant of canine lymphoma is diffuse large B-cell lymphoma, which, if treated with multiagent chemotherapy, has a survival time of approximately 12 months. T-cell lymphomas are more heterogeneous and high- and low-grade variants are common, which necessitates classification beyond B- versus T-cell lineage.

AB - Lymphoma in dogs is a heterogeneous cancer with highly variable prognosis. Many types of canine lymphoma have similar counterparts in the World Health Organization classification of human lymphoid tumors. The most common variant of canine lymphoma is diffuse large B-cell lymphoma, which, if treated with multiagent chemotherapy, has a survival time of approximately 12 months. T-cell lymphomas are more heterogeneous and high- and low-grade variants are common, which necessitates classification beyond B- versus T-cell lineage.

KW - Clonal antigen receptor polymerase chain reaction

KW - Flow cytometry

KW - Immunohistochemistry

KW - Lymphosarcoma

KW - Veterinary

KW - WHO classification

UR - http://www.scopus.com/inward/record.url?scp=79551485520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551485520&partnerID=8YFLogxK

U2 - 10.1016/j.cll.2010.10.001

DO - 10.1016/j.cll.2010.10.001

M3 - Article

VL - 31

SP - 21

EP - 39

JO - Clinics in Laboratory Medicine

JF - Clinics in Laboratory Medicine

SN - 0272-2712

IS - 1

ER -